SK channels; IK channels; electrophysiology; afterhyperpolarization; monoaminergic neurones; transfected cell lines; patch clamp
Abstract :
[en] We have recently shown that the alkaloid methyl-laudanosine blocks SK channel-mediated afterhyperpolarizations (AHPs) in midbrain dopaminergic neurones. However, the relative potency of the compound on the SK channel subtypes and its ability to block AHPs of other neurones were unknown. Using whole-cell patch-clamp experiments in transfected cell lines, we found that the compound blocks SK1, SK2 and SK3 currents with equal potency: its mean IC(50)s were 1.2, 0.8 and 1.8 microM, respectively. IK currents were unaffected. In rat brain slices, methyl-laudanosine blocked apamin-sensitive AHPs in serotonergic neurones of the dorsal raphe and noradrenergic neurones of the locus coeruleus with IC(50)s of 21 and 19 microM, as compared to 15 microM in dopaminergic neurones. However, at 100 microM, methyl-laudanosine elicited a constant hyperpolarization of serotonergic neurones of about 9 mV, which was inconsistently (i.e. not in a reproducible manner) antagonized by atropine and hence partly due to the activation of muscarinic receptors. While exploring the pharmacology of related compounds, we found that methyl-noscapine also blocked SK channels. In cell lines, methyl-noscapine blocked SK1, SK2 and SK3 currents with mean IC(50)s of 5.9, 5.6 and 3.9 microM, respectively. It also did not block IK currents. Methyl-noscapine was slightly less potent than methyl-laudanosine in blocking AHPs in brain slices, its IC(50)s being 42, 37 and 29 microM in dopaminergic, serotonergic and noradrenergic neurones, respectively. Interestingly, no significant non-SK effects were observed with methyl-noscapine in slices. At a concentration of 300 microM, methyl-noscapine elicited the same changes in excitability in the three neuronal types than did a supramaximal concentration of apamin (300 nM). Methyl-laudanosine and methyl-noscapine produced a rapidly reversible blockade of SK channels as compared with apamin. The difference between the IC(50)s of apamin (0.45 nM) and methyl-laudanosine (1.8 microM) in SK3 cells was essentially due to a major difference in their k(-1) (0.028 s(-1) for apamin and >or=20 s(-1) for methyl-laudanosine). These experiments demonstrate that both methyl-laudanosine and methyl-noscapine are medium potency, quickly dissociating, SK channel blockers with a similar potency on the three SK subtypes. Methyl-noscapine may be superior in terms of specificity for the SK channels.
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Scuvée-Moreau, Jacqueline ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Pharmacologie - Département des sciences biomédicales et précliniques
Boland, André ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
ABIA, A., LOBATON, C., MORENO, A. & GARCIA-SANCHO, J. (1986). Leiurus quinquestriatus venom inhibits different kinds of Ca 2+-dependent K + channels. Biochim. Biophys. Acta - Biomembranes, 856, 403-407.
ADEAGBO, A.S.O. (1999). 1-Ethyl-2-benzimidazolinone stimulates endothelial K ca channels and nitric oxide formation in rat mesenteric vessels. Eur. J. Pharmacol., 379, 151-159.
ANTONARAKIS, SE., BLOUIN, J.L., LASSETER, V.K., GEHRIG, C., RADHAKRISHNA, U., NESTADT, G., HOUSMAN, D.E., KAZAZIAN, H.H., KALMAN, K., GUTMAN, G., FANTINO, E., CHANDY, K.G., GARGUS, J.J. & PULVER, A.E. (1999). Lack of linkage or association between schizophrenia and the polymorphic trinucleotide repeat within the KCNN3 gene on chromosome 1q21. Am. J. Med. Genet., 88, 348-351.
ARMSTRONG, C.M. & GILLY, W.F. (1992). Access resistance and space clamp problems associated with whole-cell patch clamping. In: Methods in Enzymology, ed. Rudy, B. & Iverson, L.E. Vol. 207, pp. 100-122. San Diego: Academic Press.
BENTON, D.C., MONAGHAN, A.S., HOSSEINI, R., BAHIA, P.K., HAYLETT, D.G. & MOSS, G.W. (2003). Small conductance Ca 2+-activated K + channels formed by the expression of rat SK1 and SK2 genes in HEK 293 cells. J. Physiol., 553, 13-19.
BONNET-BRILHAULT, F., LAURENT, C., CAMPION, C., CAMPION, D., THIBAUT, F., LAFARQUE, C., CHARBONNIER, F., DELEUZE, J.F., MENARD, J.F., JAY, M., PETIT, M., FREBOURG, T. & MALLET, J. (1999). No evidence for involvement of KCNN3 (hSKCa3) potassium channel gene in familial and isolated cases of schizophrenia. Eur. J. Hum. Genet., 7, 247-250.
CAMPOS ROSA, J., GALANAKIS, D., PIERGENTILI, A., BHANDARI, K., GANELLIN, C.R., DUNN, P.M. & JENKINSON, D.H. (2000). Synthesis, molecular modeling, and pharmacological testing of bisquinolinium cyclophanes: potent, non-peptidic blockers of the apamin-sensitive Ca 2+-activated K + channel. J. Med. Chem., 43, 420-431.
CAO, Y.J., DREIXLER, J.C., ROIZEN, J.D., ROBERTS, M.T. & HOUAMED, K.M. (2001). Modulation of recombinant small-conductance Ca 2+- activated K + channels by the muscle relaxant chlorzoxazone and structurally related compounds. J. Pharmacol. Exp. Ther., 296, 683-689.
CAO, Y.J. & HOUAMED, K.M. (1999). Activation of recombinant human SK4 channels by metal cations. FEBS Lett., 446, 137-141.
CHEN, H., KIM, L.A., RAJAN, S., XU, S. & GOLDSTEIN, S.A.N. (2003). Charybdotoxin binding in the I Ks pore demonstrates two MinK subunits in each channel complex. Neuron, 40, 15-23.
CHICCHI, G.G., GIMENEZ-GALLEGO, G., BER, E., GARCIA, M.L., WINQUIST, R. & CASCIERI, M.A. (1988). Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venom. J. Biol. Chem., 263, 10192-10197.
CINGOLANI, L.A., GYMNOPOULOS, M., BOCCACCIO, A., STOCKER, M. & PEDARZANI, P. (2002). Developmental regulation of small-conductance Ca 2+-activated K + channel expression and function in rat Purkinje neurons. J. Neurosci., 22, 4456-4467.
DALE, T.J., CRYAN, J.E., CHEN, M.X. & TREZISE, D.J. (2002). Partial apamin sensitivity of human small conductance Ca 2+-activated K + channels stably expressed in Chinese hamster ovary cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 366, 470-477.
DROR, V., SHAMIR, E., GHANSHANI, S., KIMHI, R., SWARTZ, M., BARAK, Y., WEIZMAN, R., AVIVI, L., LITMANOVITCH, T., FANTINO, E., KALMAN, K., JONES, E.G., CHANDY, K.G., GARGUS, J.J., GUTMAN, G.A. & NAVON, R. (1999). hKCa3/ KCNN3 potassium channel gene: association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21. Mol. Psychiatry, 4, 254-260.
FINLAYSON, K., MCLUCKIE, J., HERN, J., ARAMORI, I., OLVERMAN, H.J. & KELLY, J.S. (2001). Characterisation of [ 125I]-apamin binding sites in rat brain membranes and HEK293 cells transfected with SK channel subtypes. Neuropharmacology, 41, 341-350.
GUTMAN, G.A., CHANDY, G., ADELMAN, J.P., AIYAR, J., BAYLISS, D.A., CLAPHAM, D.E., COVARRIUBIAS, M., DESIR, G.V., FURUICHI, K., GANETZKY, B., GARCIA, M.L., GRISSMER, S., JAN, L.Y., KARSHIN, A., KIM, D., KUPERSCHMIDT, S., KURACHI, Y., LAZDUNSKI, M., LESAGE, F., LESTER, H.A., MCKINNON, D., NICHOLS, G., O'KELLY, I., ROBBINS, J., ROBERTSON, A., RUDY, B., SANGUINETTI, M., SEINO, S., STUEHMER, W., TAMKUN, M.M., VANDENBERG, C.A., WEI, A., WULFF, H. & WYMORE, R.S. (2003). International Union of Pharmacology, XLI. Compendium of voltage-gated ion channels: potassium channels. Pharmacol. Rev., 55, 583-586.
HABERMANN, E. & CHENG-RAUDE, D. (1975). Central neurotoxicity of apamin, crotamin, phospholipase A and α-amanitin. Toxicon, 13, 465-473.
HILLE, B. (2001). Ion Channels of Excitable Membranes, 3rd edn. Sunderland, MA, U.S.A.: Sinauer Associates, Inc..
IKONEN, S. & RIEKKINEN Jr, P. (1999). Effects of apamin on memory processing of hippocampal-lesioned mice. Eur. J. Pharmacol., 382, 151-156.
INNIS, R.B., NESTLER, E.J. & AGHAJANIAN, G.K. (1988). Evidence for G protein mediation of serotonin- and GABAB-induced hyperpolarization of rat dorsal raphe neurons. Brain Res., 459, 27-36.
ISHII, T.M., MAYLIE, J. & ADELMAN, J.P. (1997). Determinants of apamin and d-tubocurarine block in SK potassium channels. J. Biol. Chem., 272, 23195-23200.
JENSEN, B.S., STROBAEK, D., CHRISTOPHERSEN, P., JORGENSEN, T.D., HANSEN, C., SILAHTAROGLU, A., OLESEN, S.P. & AHRING, P.K. (1998). Characterization of the cloned human intermediate-conductance Ca 2+-activated K + channel. Am. J. Physiol. Cell Physiol., 275, C848-C856.
KAPUR, S. & SEEMAN, P. (2001). Does fast dissociation from the dopamine D(2) receptor explain the action of atypical antipsychotics ?: a new hypothesis. Am. J. Psychiatry, 158, 360-369.
KÖHLEZ, M., HIRSCHBERG, B., BOND, C.T., KINZIE, J.M., MARRION, N.V., MAYLIE, J. & ADELMAN, J.P. (1996). Small-conductance, calcium-activated potassium channels from mammalian brain. Science, 273, 1709-1714.
LATORRE, R., OBERHAUSER, A., LABARCA, P. & ALVAREZ, O. (1989). Varieties of Ca 2+-activated K + channels. Annu. Rev. Physiol., 51, 385-399.
LEGROS, C., OUGHUIDENI, R., DARBON, H., ROCHAT, H., BOUGIS, P.E. & MARTIN-EAUCLAIRE, M.F. (1996). Characterization of a new peptide from Tityus serrulatus scorpion venom which is a ligand of the apamin binding site. FEBS Lett., 390, 81-84.
LIÉGEOIS, J.-F., MERCIER, F., GRAULICH, A., GRAULICH-LORGE, F., SCUVEE-MOREAU, J. & SEUTIN, V. (2003). Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry. Curr. Med. Chem., 10, 625-647.
MILLER, M., RAUER, H., TOMITA, H., GARGUS, J.J., GUTMAN, G.A., CAHALAN, G.A. & CHANDY, K.G. (2001). Nuclear localization and dominant-negative suppression by a mutant SKCa3 N-terminal channel fragment identified in a patient with schizophrenia. J. Biol. Chem., 276, 27753-27756.
MONAGHAN, A.S., BENTON, D.C., BAHIA, P.K., HOSSEINI, R., SHAH, Y.A., HAYLETT, D.G. & MOSS, G.W. (2004). The SK3 subunit of small conductance Ca 2+-activated K + channels interacts with both SK1 and SK2 subunits in a heterologous expression system. J. Biol. Chem., 279, 1003-1009.
MOURRE, C., FOURNIER, C. & SOUMIREU-MOURAT, B. (1997). Apamin, a blocker of the calcium-activated potassium channel, induces neurodegeneration of Purkinje cells exclusively. Brain Res., 778, 405-408.
PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Coordinates, 2nd edn. San Diego, CA, U.S.A.: Academic Press.
PEDARZANI, P., D'HOEDT, D., DOORTY, K.B., WADSWORTH, J.D., JOSEPH, J.S., JEYASEELAN, K., KINI, R.M., GADRE, S.V., SAPATNEKAR, S.M., STOCKER, M. & STRONG, P.N. (2002). Tamapin, a venom peptide from the Indian scorpion (Mesobuthus tamulus) that targets small-conductance Ca 2+-activated K + channels and afterhyperpolarization currents in central neurons. J. Biol. Chem., 277, 46101-46109.
PEDARZANI, P., KULIK, A., MULLER, M., BALLANYI, K. & STOCKER, M. (2000). Molecular determinants of Ca 2+-dependent K + channel function in rat dorsal vagal neurones. J. Physiol. (Lond.), 527, 283-290.
PEDARZANI, P., MOSBACHER, J., RIVARD, A., CINGOLANI, L.A., OLIVER, D., STOCKER, M., ADELMAN, J.P. & FAKLER, B. (2001). Control of electrical activity in central neurons by modulating the gating of small conductance Ca 2+-activated K + channels. J. Biol. Chem., 276, 9762-9769.
RITSNER, M., MODAI, I., ZIV, H., AMIR, S., HALPERIN, T., WEIZMAN, R. & NAVON, R. (2002). An association of CAG repeats at the KCNN3 locus with symptom dimensions of schizophrenia. Biol. Psych., 51, 788-794.
SAH, P. (1996). Ca 2+-activated K + currents in neurones: types, physiological roles and modulation. Trends Neurosci., 19, 150-154.
SAILER, C.A., HU, H., KAUFMANN, W.A., TRIEB, M., SCHWARZER, C., STORM, J.F. & KNAUS, H.G. (2002). Regional differences in distribution and functional expression of small-conductance Ca 2+-activated K + channels in rat brain. J. Neurosci., 22, 9698-9707.
SCUVÉE-MOREAU, J., GRAULICH, A., LIEGEOIS, J.-F. & SEUTIN, V. (2004). Effect of the SK channel blocker N-methyl-laudanosine on brainstem monoaminergic neurons in slices: differences among its stereoisomers. Soc. Neurosci. Abstr., (In press).
SCUVÉE-MOREAU, J., LIEGEOIS, J.-F., MASSOTTE, L. & SEUTIN, V. (2002). Methyl-laudanosine: a new pharmacological tool to investigate the function of small-conductance Ca 2+-activated K + channels. J. Pharmacol. Exp. Ther., 302, 1176-1183.
SEUTIN, V. & JOHNSON, S.W. (1999). Recent advances in the pharmacology of quaternary salts of bicuculline. Trends Pharmacol. Sci., 20, 268-270.
SEUTIN, V., MASSOTTE, L., LIEGEOIS, J.-F. & SCUVEE-MOREAU, J. (2002). Effect of a new SK channel blocker, methyl-laudanosine, on the firing pattern of rat midbrain dopaminergic neurons in vivo. Soc. Neurosci. Abst., 28, 340 .5.
SEUTIN, V., SCUVEE-MOREAU, J. & DRESSE, A. (1997). Evidence for a non-GABAergic action of quarternary salts of bicuculline on dopaminergic neurones. Neuropharmacology, 36, 1653-1657.
SHAKKOTTAI, V.G., REGAYA, I., WULFF, H., FAJLOUN, Z., TOMITA, H., FATHALLAH, M., CAHALAN, M.D., GARGUS, J.J., SABATIER, J.-M. & CHANDY, K.G. (2001). Design and characterization of a highly selective peptide inhibitor of the small conductance calcium-activated K + channel, SkCa2. J. Biol. Chem., 276, 43145-43151.
STACKMAN, R.W., HAMMOND, R.S., LINARDATOS, E., GERLACH, A., MAYLIE, J., ADELMAN, J.P. & TZOUNOPOULOS, T. (2002). Small conductance Ca 2+-activated K + channels modulate synaptic plasticity and memory encoding. J. Neurosci., 22, 10163-10171.
STOCKER, M., HIRZEL, K., D'HOEDT, D. & PEDARZANI, P. (2004). Matching molecules to function: neuronal Ca 2+-activated K + channels and afterhyperpolarizations. Toxicon, 43, 933-949.
STOCKER, M., KRAUSE, M. & REDARZANI, P. (1999). An apaminsensitive Ca 2+-activated K + current in hippocampal pyramidal neurons. Proc. Natl. Acad. Sci. U.S.A., 96, 4662-4667.
STOCKER, M. & PEDARZANI, P. (2000). Differential distribution of three Ca 2+-activated K + channel subunits SK(1-3) in the adult rat central nervous system. Mol. Cell. Neurosci., 15, 476-493.
TSAI, M.T., SHAW, C.K., HSIAO, K.J. & CHEN, C.H. (1999). Genetic association study of a polymorphic CAG repeats array of calcium-activated potassium channel (KCNN3) gene and schizophrenia among the Chinese population from Taiwan. Mol. Psych., 4, 271-273.
VAN DER STAAY, F.J., FANELLI, R.J., BLOCKLAND, A. & SCHMIDT, B.H. (1999). Behavioral effects of apamin, a selective inhibitor of the SK Ca-channel, in mice and rats. Neurosci. Biobehav. Rev., 23, 1087-1110.
VANDERMAELEN, C.P. & AGHAJANIAN, G.K. (1983). Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res., 289, 109-119.
WOLFART, J., NEUHOFF, H., FRANZ, O. & ROEPER, J. (2001). Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J. Neurosci., 21, 3443-3456.
XIA, X.M., FAKLER, B., RIVARD, A., WAYMAN, G., JOHNSON-PAIS, T., KEEN, J.E., ISHII, T., HIRSCHBERG, B., BOND, C.T., LUTSENKO, S., MAYLIE, J. & ADELMAN, J.P. (1998). Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature, 395, 503-507.
ZERROUK, H., MANSUELLE, P., BENSLIMANE, A., ROCHAT, H. & MARTIN-EAUCLAIRE, M.F. (1993). Characterization of a new leiurotoxin I-like scorpion toxin PO5 from Androctonus mauretanicus mauretanicus. FEBS Lett., 320, 189-192.